14,987 reports of this reaction
4.2% of all LEVONORGESTREL reports
#3 most reported adverse reaction
MENSTRUATION IRREGULAR is the #3 most commonly reported adverse reaction for LEVONORGESTREL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 14,987 FDA adverse event reports linking LEVONORGESTREL to MENSTRUATION IRREGULAR. This represents approximately 4.2% of all 357,584 adverse event reports for this drug.
Patients taking LEVONORGESTREL who experience menstruation irregular should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MENSTRUATION IRREGULAR is moderately reported among LEVONORGESTREL users, representing a notable but not dominant share of adverse events.
In addition to menstruation irregular, the following adverse reactions have been reported for LEVONORGESTREL:
The following drugs have also been linked to menstruation irregular in FDA adverse event reports:
MENSTRUATION IRREGULAR has been reported as an adverse event in 14,987 FDA reports for LEVONORGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
MENSTRUATION IRREGULAR accounts for approximately 4.2% of all adverse event reports for LEVONORGESTREL, making it one of the most commonly reported side effect.
If you experience menstruation irregular while taking LEVONORGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.